Locations:
Search IconSearch

Cancer

22-CNR-2877719-CQD-Hero-650×450-1
May 25, 2022/Cancer/Research

Embracing the Emerging Role of “Expert” Patients in Cancer Care

How online education is redefining the patient-provider relationship

PSA positive
May 20, 2022/Cancer

Real-World Study Supports IsoPSA as a Prostate Cancer Biomarker

Reflex testing led to substantially fewer provider recommendations for prostate biopsy and MRI

650×450-partial-nephrectomy
May 16, 2022/Cancer

For Cancer in a Solitary Kidney, Preserving Function Is Almost Always Possible

Analysis is one of the largest-ever series of RMSK outcomes, first to include all RMSK patients

gettyimages-958769278-170667a-1
May 6, 2022/Cancer/Innovations

The Changing Treatment Landscape for Patients with Metastatic Melanoma

Immune therapy and targeted therapies have led to durable responses and potential cures

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2892117_vestibular-schwannomas-meningiomas_650x450
May 5, 2022/Cancer

Large Series Finds Monitoring Acceptable for Most Meningiomas in Patients With Neurofibromatosis Type 2

Younger patients and those with peritumoral brain edema warrant closer follow-up, earlier treatment

22-DDI-2861960 Young onset CRC hero image 650×450
May 3, 2022/Cancer

Quantifying the Prevalence of Neoplasia in Young Adults Undergoing Diagnostic Colonoscopy

Retrospective study results underscore the need for colonoscopy in symptomatic people under age 50

22-NEU-2763298-060-CQD-Hero-650×450-v2
April 28, 2022/Cancer

Gamma Knife for Brain Tumors: Latest Developments and What’s on the Horizon

Two stereotactic radiosurgery experts take stock after Cleveland Clinic’s 10,000th case

22-CNR-2819722-CQD-Hero-650×450-1
April 27, 2022/Cancer/Blood Cancers

Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study

Novel three-drug regimen used to manage life-threatening developments

22-CNR-2800312-CQD-Hero-650×450-1
April 25, 2022/Cancer/Research

MCL1 in the Nucleus Appears to Drive Chemoresistance in Colorectal Cancer

Bcl-xL inhibitors may help overcome this complication

22-CNR-IV-Drip-CQD-Hero-650×450-1
April 20, 2022/Cancer/Tumor Oncology

Combination Chemo-Immunotherapy Appears to Improve Outcomes in Muscle-Invasive Bladder Cancer

New results from the BLASST-1 trial show increases in downstaging and relapse-free survival

BackPage 26 of 137Next

Advertisement

Ad